SS

Shailesh Siroya

Active Director Managing Director DIN 00048109
DIN 00048109 First appointment May 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 12 historical roles
Total affiliations 18 Since May 1992
Shareholding value •••• Premium profile

About Shailesh Siroya

Data last updated:

Shailesh Siroya is a Managing Director at Bal Pharma Limited (since 2004), Director at Lifezen Healthcare Private Limited (since 2014) and Director at Kaunshya Investments Private Limited (since 2022), and holds 3 more current directorships. The companies operate in Pharma, Financial Services and Professional Services. The 4 current companies with reported revenue have a combined latest revenue of ₹306 Cr; the largest is Bal Pharma Limited at ₹305 Cr (FY 2025). Earlier, Shailesh Siroya was a Director at E-Xseed Technologies And Devices Private Limited (2005–2014) and Director at Gajkeshri Mines And Minerals Private Limited (2017–2018) and 10 more.

DIN 00048109
Primary Designation Managing Director
Industry Pharma
First Appointment 15 May 1992
Oldest Company Age 39 yrs
Largest company Bal Pharma Limited · ₹305 Cr (FY 2025)
Combined revenue ₹306 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bal Pharma Limited L85110KA1987PLC008368
Managing Director01 Aug 20041987₹305 Cr (FY 2025)Active
Lifezen Healthcare Private Limited U24230KA2014PTC077114
Director07 Nov 20142014₹76.6 Lakh (FY 2025)Active
Kaunshya Investments Private Limited U67120KA1994PTC016853
Director25 Jan 20221994₹7.3 Lakh (FY 2025)Active
Bal Research Foundation U73100KA2014NPL076995
Director22 Dec 20142014₹55,000 (FY 2023)Active
Director21 Aug 20232023Active
Designated Partner15 May 20142014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20052005Strike Off
Director31 Mar 20172016Active
Indo-Middleeast Chamber Of Commerce U73100KA2003NPL033078
Director23 Dec 20032003₹72,000 (FY 2025)Active
Sunil Agro Foods Limited L01111KA1988PLC008861
Director28 Jul 20031988₹231 Cr (FY 2025)Active
Golden Drugs Private Limited U24232KA2012PTC157474
Director12 Apr 20182012₹5.80 Cr (FY 2024)Amalgamated
Basav Chem Limited U24233KA1996PLC049815
Director06 Dec 20071996Amalgamated
Sanjay Gems Pvt Ltd U36911MH1989PTC051495
Director15 May 19921989Strike Off
Director21 Apr 20082008Strike Off
Director18 Jul 20082008Strike Off
Director28 Jan 20132013Strike Off
Director10 Aug 20012001Strike Off
Designated Partner22 Aug 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Shailesh Siroya

NameDINCompanyDesignation
Bheekamchand Mukesh11295580Bal Pharma LimitedAdditional Director
Daddanala Venkat Bharath BhushanBal Pharma LimitedCfo
Jatish Sheth00581963Bal Pharma LimitedDirector
Makkigadde Lakshminarayana ShreepadaBal Pharma LimitedCompany Secretary
Nicola Neeladri01997936Bal Pharma LimitedDirector
Ravindrakumar Kothari03418320Bal Pharma Limited , Lifezen Healthcare Private Limited and 3 moreDirector
Virupakshaya Himesh08554422Bal Pharma LimitedWhole-Time Director
Promod Khanna00906613Kaunshya Investments Private LimitedDirector
Rajesh Mehta00177508Kaunshya Investments Private LimitedDirector
Tim Mathews02780353Kaunshya Investments Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kaunshya Investments Private Limited
Bal Pharma Limited
Lifezen Healthcare Private Limited
Golden Drugs Private Limited
Premium access

Shareholding and investment profile for Shailesh Siroya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Siroya

Shailesh Siroya currently holds 6 directorships: Bal Pharma Limited (Managing Director, since 01 Aug 2004, revenue ₹305 Cr (FY 2025)); Lifezen Healthcare Private Limited (Director, since 07 Nov 2014, revenue ₹76.6 Lakh (FY 2025)); Kaunshya Investments Private Limited (Director, since 25 Jan 2022, revenue ₹7.3 Lakh (FY 2025)); Bal Research Foundation (Director, since 22 Dec 2014, revenue ₹55,000 (FY 2023)); Aurum Research & Analytical Solutions Private Limited (Director, since 21 Aug 2023); and 1 more.

Shailesh Siroya was first appointed on 15 May 1992 as Director at Sanjay Gems Pvt Ltd. The most recent appointment on record is 21 Aug 2023 at Aurum Research & Analytical Solutions Private Limited.

The 4 current companies of Shailesh Siroya that report revenue have a combined latest revenue of ₹306 Cr: Bal Pharma Limited ₹305 Cr (FY 2025); Lifezen Healthcare Private Limited ₹76.6 Lakh (FY 2025); Kaunshya Investments Private Limited ₹7.3 Lakh (FY 2025); Bal Research Foundation ₹55,000 (FY 2023).

Shailesh Siroya held 12 earlier board appointments: E-Xseed Technologies And Devices Private Limited (Director, 23 Sep 2005 to 25 Sep 2014); Gajkeshri Mines And Minerals Private Limited (Director, 31 Mar 2017 to 28 Nov 2018); Indo-Middleeast Chamber Of Commerce (Director, 23 Dec 2003 to 30 Jul 2014); Sunil Agro Foods Limited (Director, 28 Jul 2003 to 12 Nov 2018); Golden Drugs Private Limited (Director, from 12 Apr 2018); and 7 more.

The current boards of Shailesh Siroya's companies include Bheekamchand Mukesh (Bal Pharma Limited), Daddanala Venkat Bharath Bhushan (Bal Pharma Limited), Jatish Sheth (Bal Pharma Limited), Makkigadde Lakshminarayana Shreepada (Bal Pharma Limited), Nicola Neeladri (Bal Pharma Limited), Ravindrakumar Kothari (Bal Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available